In detail, AD results from Th2 inflammation mediated by both IL-4 and IL-13, and dupilumab shows the greatest inhibition of Th2 inflammation and impressive power in controlling AD-related pruritus. The gene discussed is IL4; the disease is Alzheimer disease.